跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 51 条关于
“DNBelab-C4”
全部
51
临床试验
19
药物
9
机构
1
资讯
22
去年
MGI Tech and JCBio Launch Strategic Partnership to Advance Multi-Omics Research in South Korea
去年
C4 Therapeutics Stock Hits 52-Week Low Amid Market Volatility
5个月前
C4 Therapeutics and Roche Expand Partnership with $1 Billion+ DAC Collaboration
去年
C4 Therapeutics Announces 2025 Milestones for Oncology-Focused Degrader Medicines
2年前
C4 Therapeutics' CFT1946 Shows Promise in BRAF V600 Mutant Solid Tumors
8个月前
C4 Therapeutics Advances Cemsidomide Through Phase 2 Development as Potential Best-in-Class Multiple Myeloma Treatment
去年
FDA Accepts IND Application for BIIB142, First IRAK4 Degrader to Enter Clinical Development for Autoimmune Diseases
去年
cGAS-STING Pathway Shows Dual Role in Breast Cancer Immunotherapy Response
去年
Novel Metabolic Signatures Show Promise for Earlier Pancreatic Cancer Detection and Prognosis
去年
FDA Expands Indications for Cerapedics' i-FACTOR Bone Graft in Cervical Spinal Fusion
第 1 页,共 3 页
上一页
下一页